Market players have been launching new carrier screening products to help people in making informed and early decisions about their health.
Carrier Screening Industry Overview:
Market players have been launching new carrier screening products to help people in making informed and early decisions about their health. From launching new panels to developing at-home kits for testing, market players have been striving to bring hew products to improve health outcomes of pregnant women and newborn babies. Early information about possibility of contracting diseases and various conditions in newborns will assist parents in opting necessary treatment. So, the demand for carrier screening tests is expected to increase in the coming years. According to the report published by Allied Market Research, the global carrier screening market is estimated to reach $4.00 billion by 2030. Following are some of the activities taking place across the world.
Market players have been launching new products to solve the existing issues and improve healthcare systems. NxGen MDx launched Early Advantage Panel for enhancing outcomes for pregnant women and newborns. This is an innovative approach for carrier screening and designed by incorporating recommendations by the U.S. Department of Health and Human Services (HHS) for newborn screening (NBS). Commenting on the launch, Jacqueline Peacock, PhD and Director of Laboratory Operations at NxGen, highlighted that the company provided this panel to obtain accurate and early results for carrying out diagnostic testing, explore treatment options, and save lives of newborns.
The new panel plays a crucial role in determining the at-risk couples during or before pregnancy. It complements the NBS program. So, parents can gain valuable insights and avail better treatment options than relying only on NBS. The company adopted the philosophy of NatalCare for development of its products. Along with this philosophy and development of best-in-class carrier screening methods, the company aims to reduce genetic health concerns and provide early information to parents. This leads to making informed and rapid decisions related to health of a pregnant woman and a newborn.
The trend of launch of new products continues with Mitera launching at-home carrier screening product 23Pears. This product is an expanded carrier screening (ECS) test that enables couples in determining the chances of contracting one of the 421 inherited conditions by their babies. These conditions include cystic fibrosis, sickle cell anemia, and others. The company delivers the test kits to homes of patients and provides sample containers and instructions to carry out these tests successfully at home. Moreover, it offers consultation with medical specialists if required. Such innovative products will continue to be launched in the coming years.
Request for Sample Report for More Insights @ https://www.alliedmarketresearch.com/request-sample/11636
Top Leading Players:
- Eurofins Scientific
- Invitae Corporation
- Opko Health
- Fulgent Genetics Inc.
- Quest Diagnostics Incorporated
- Natera Inc.
- Myriad Genetics
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Luminex Corporation
Covid-19 Scenario-
Here, it’s worth mentioning that the outbreak of the Covid-19 pandemic gave way to adjournment of the majority of elective surgeries across the world, which in turn resulted into a steep decline in demand for Carrier Screening, thereby impacting the market negatively, especially during the initial period. However, as the global situation is getting back to normalcy, the market is also projected to revive soon.